Second annual JBC Methods Madness tournament begins next week
Calling all scientists! The Journal of Biological Chemistry’s second annual Methods Madness tournament is here.
Last year’s tournament came down to the wire with #TeamCryo scraping by #TeamMassSpec to be crowned the first ever #JBCMethodsMadness champion. Can #TeamCryo repeat this year? Will #TeamMassSpec get revenge? Will both be upset by a new contender? Now is your chance to decide who makes it through.
The madness begins on Monday. (See tournament schedule below). Submit your bracket by Sunday for a chance to win a $100 gift card.
Round 1: The Scientific 16
Vote for your favorite methods by participating in polls posted by @jbiolchem.
Monday, March 15
9 a.m. – #TeamMassSpec vs. #TeamFRET
2 p.m. – #TeamImmuno vs. #TeamXRC
Tuesday, March 16
9 a.m. – #TeamCryo vs. #TeamMachine
2 p.m. – #TeamiPSC vs. #TeamLiveCell
Wednesday, March 17
9 a.m. – #TeamPCR vs. #TeamChroma
2 p.m. – #TeamCloning vs. #TeamNMR
Thursday, March 18
9 a.m. – #TeamCRISPR vs. #TeamSuperRes
2 p.m. – #TeamOmics vs. #TeamOpto
All times Eastern.
A note about JBC methods
It's well known that science progresses by building on the shoulders of those who came before. That's especially true for papers that report new tools — genetic constructs, small molecules, model organisms, etc. — that can be directly used by colleagues to jump-start a new project or resolve a technical hurdle. And at JBC, our high standards for rigor and reproducibility mean that readers can trust published tools to work as promised.
— Lila Gierasch, JBC editor-in-chief
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.
Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.
Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.
The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.
Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.
Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.